Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-11-25
|
pubmed:abstractText |
Solid tumours require neovascularization for growth and metastasis. Both vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) are well-characterized inducers of angiogenesis. In this study we examined the expressions of these antigens and their relationship with microvessel density and also determined their prognostic significance. Ninety-five specimens resected from patients with gastric carcinoma were investigated using immunohistochemical methods. Microvessel density, determined by immunostaining for factor VIII-related antigen, was significantly higher in tumours that were both VEGF+ and PD-ECGF+ than in tumours that were both VEGF- and PD-ECGF-. According to prognosis, patients with VEGF+ tumours had a significantly worse prognosis than did those with VEGF- tumours. Although there was no significant correlation between PD-ECGF expression and prognosis, patients with PD-ECGF+ tumours tended to have a shorter survival than did those with PD-ECGF- tumours. Moreover, the frequency of hepatic recurrence was significantly higher in patients with tumours that were both VEGF-positive and PD-ECGF+ than in all other patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine Phosphorylase,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-50
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:9355979-Adult,
pubmed-meshheading:9355979-Aged,
pubmed-meshheading:9355979-Antigens, Neoplasm,
pubmed-meshheading:9355979-Endothelial Growth Factors,
pubmed-meshheading:9355979-Female,
pubmed-meshheading:9355979-Gastric Mucosa,
pubmed-meshheading:9355979-Humans,
pubmed-meshheading:9355979-Immunohistochemistry,
pubmed-meshheading:9355979-Lymphokines,
pubmed-meshheading:9355979-Male,
pubmed-meshheading:9355979-Middle Aged,
pubmed-meshheading:9355979-Prognosis,
pubmed-meshheading:9355979-Stomach Neoplasms,
pubmed-meshheading:9355979-Thymidine Phosphorylase,
pubmed-meshheading:9355979-Vascular Endothelial Growth Factor A,
pubmed-meshheading:9355979-Vascular Endothelial Growth Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma.
|
pubmed:affiliation |
First Department of Surgery, Osaka City University Medical School, Osaka, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|